Literature DB >> 8983024

Positive and negative modulation of H-ras transforming potential by mutations of phenylalanine-28.

M H Ricketts1, G A Durrheim, H M North, M J van der Merwe, A D Levinson.   

Abstract

Conserved amino-acids of H-ras from residues 25 to 34 were mutated in human H-ras cDNA with a pre-existing valine-12 activating mutation ([V12]p21), and built into SV40-driven expression vectors. The influence of the introduced mutations was initially screened by transfection of Rat-1 cells to score foci of transformed cells. Non-conservative mutations of amino-acids 25 (tryptophan for glutamine), 27 (asparagine for histidine) and 34 (alanine for proline) did not abrogate the transforming potential of [V12]p21. The conservative mutation of phenylalanine-28 to tryptophan ([V12W28]p21) was also still transforming. Significantly, in the absence of the valine-12 activating mutation, tryptophan-28-ras ([W28]p21) was weakly transforming while, in contrast, [V12D28]p21 was unable to transform Rat-1 cells and retarded cell growth. Analysis of the binding and dissociation of GTP and GDP to normal and mutated p21 expressed in Escherichia coli showed that [V12D28]p21 and [D28]p21 do not bind GTP. The dissociation rate of both GTP and GDP bound to [W28]p21 is increased, suggesting a mechanism for its transforming potential in Rat-1 cells. These studies illustrate the importance of phenylalanine-28 in guanine nucleotide binding by p21H-ras. The mutations described could be valuable tools in investigations of cellular signal transduction involving small GTP-binding proteins.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8983024     DOI: 10.1007/bf00424436

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  35 in total

1.  Stimulation of p21ras upon T-cell activation.

Authors:  J Downward; J D Graves; P H Warne; S Rayter; D A Cantrell
Journal:  Nature       Date:  1990-08-23       Impact factor: 49.962

2.  Dominant inhibitory Ras mutants selectively inhibit the activity of either cellular or oncogenic Ras.

Authors:  D W Stacey; L A Feig; J B Gibbs
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

3.  Genetic definition of ras effector elements.

Authors:  J C Stone; R A Blanchard
Journal:  Mol Cell Biol       Date:  1991-12       Impact factor: 4.272

4.  Conformational effects of nucleotide exchange in ras p21 proteins as studied by fluorescence spectroscopy.

Authors:  J V Skelly; D A Suter; R Kuroda; S Neidle; J F Hancock; A Drake
Journal:  FEBS Lett       Date:  1990-03-12       Impact factor: 4.124

5.  S. cerevisiae genes IRA1 and IRA2 encode proteins that may be functionally equivalent to mammalian ras GTPase activating protein.

Authors:  K Tanaka; M Nakafuku; T Satoh; M S Marshall; J B Gibbs; K Matsumoto; Y Kaziro; A Toh-e
Journal:  Cell       Date:  1990-03-09       Impact factor: 41.582

6.  Three-dimensional structure of an oncogene protein: catalytic domain of human c-H-ras p21.

Authors:  A M de Vos; L Tong; M V Milburn; P M Matias; J Jancarik; S Noguchi; S Nishimura; K Miura; E Ohtsuka; S H Kim
Journal:  Science       Date:  1988-02-19       Impact factor: 47.728

7.  Chimeric proteins define variable and essential regions of Ha-ras-encoded protein.

Authors:  D G Lowe; M Ricketts; A D Levinson; D V Goeddel
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

8.  Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane.

Authors:  S J Leevers; H F Paterson; C J Marshall
Journal:  Nature       Date:  1994-06-02       Impact factor: 49.962

9.  Metabolic turnover of human c-rasH p21 protein of EJ bladder carcinoma and its normal cellular and viral homologs.

Authors:  L S Ulsh; T Y Shih
Journal:  Mol Cell Biol       Date:  1984-08       Impact factor: 4.272

10.  Comparative biochemical properties of normal and activated human ras p21 protein.

Authors:  J P McGrath; D J Capon; D V Goeddel; A D Levinson
Journal:  Nature       Date:  1984 Aug 23-29       Impact factor: 49.962

View more
  1 in total

1.  The Ras mutant D119N is both dominant negative and activated.

Authors:  R H Cool; G Schmidt; C U Lenzen; H Prinz; D Vogt; A Wittinghofer
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.